Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 10-1997 | 07-1997 | 04-1997 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 462 | 423 | 208 | 75 | 143 |
| Other Operating Activity | -2,515 | -2,113 | 771 | 1,008 | -572 |
| Operating Cash Flow | $-2,053 | $-1,691 | $979 | $1,082 | $-429 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,349 | -352 | -1,547 | -439 | -215 |
| Other Investing Activity | 1,560 | 2,184 | -503 | -926 | 1,216 |
| Investing Cash Flow | $210 | $1,832 | $-2,050 | $-1,364 | $1,001 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 831 | N/A | N/A |
| Dividend Paid | N/A | N/A | -474 | -515 | -501 |
| Other Financing Activity | 1,770 | 0 | 0 | 943 | 0 |
| Financing Cash Flow | $1,770 | $0 | $356 | $428 | $-501 |
| Beginning Cash Position | 634 | 423 | -3,484 | -3,577 | -3,648 |
| End Cash Position | 545 | 634 | -4,187 | -3,484 | -3,577 |
| Net Cash Flow | $-73 | $141 | $-715 | $146 | $72 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,053 | -1,691 | 979 | 1,082 | -429 |
| Capital Expenditure | -1,349 | -352 | -1,547 | -439 | -215 |
| Free Cash Flow | -3,403 | -2,043 | -568 | 644 | -644 |